New generation of drug delivery systems based on ginsenoside Rh2-, Lysine- and Arginine-treated highly porous graphene for improving anticancer activity
暂无分享,去创建一个
[1] F. Fesahat,et al. Sperm chromatin quality and DNA integrity in partial versus total globozoospermia , 2018, Andrologia.
[2] Byeong Cheol Jo,et al. Molecular dynamics simulation of cytotoxicity of graphene nanosheets to blood-coagulation protein. , 2017, Biointerphases.
[3] Firdous Ahmad Bhat,et al. Applications of Gold Nanoparticles in Cancer , 2017 .
[4] Chaoke Bulin,et al. High-efficient Synthesis of Graphene Oxide Based on Improved Hummers Method , 2016, Scientific Reports.
[5] Hun-Kuk Park,et al. Hemorheological characteristics of red blood cells exposed to surface functionalized graphene quantum dots. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[6] B. T. Chew,et al. Mass production of highly-porous graphene for high-performance supercapacitors , 2016, Scientific Reports.
[7] Pengyuan Yang,et al. Targeting Negative Surface Charges of Cancer Cells by Multifunctional Nanoprobes , 2016, Theranostics.
[8] Xinliang Feng,et al. Electrochemical Functionalization of Graphene at the Nanoscale with Self-Assembling Diazonium Salts. , 2016, ACS nano.
[9] J. Wen,et al. Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinase , 2016, Journal of ginseng research.
[10] J. Qian,et al. Ginsenoside-Rh2 Inhibits Proliferation and Induces Apoptosis of Human Gastric Cancer SGC-7901 Side Population Cells. , 2016, Asian Pacific journal of cancer prevention : APJCP.
[11] Kwang S. Kim,et al. Noncovalent Functionalization of Graphene and Graphene Oxide for Energy Materials, Biosensing, Catalytic, and Biomedical Applications. , 2016, Chemical reviews.
[12] Zorawar Singh,et al. Applications and toxicity of graphene family nanomaterials and their composites. , 2016, Nanotechnology, science and applications.
[13] Feifan Zhou,et al. A graphene oxide based smart drug delivery system for tumor mitochondria-targeting photodynamic therapy. , 2016, Nanoscale.
[14] Xiudong Sun,et al. Heat-Initiated Chemical Functionalization of Graphene , 2016, Scientific Reports.
[15] Leida Zhang,et al. Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy , 2016, Scientific Reports.
[16] A. Kong,et al. Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells , 2016, Oncotarget.
[17] Jiandu Lei,et al. Ginsenoside nanoparticle: a new green drug delivery system. , 2016, Journal of materials chemistry. B.
[18] B. T. Chew,et al. Microwave-Assisted Synthesis of Highly-Crumpled, Few-Layered Graphene and Nitrogen-Doped Graphene for Use as High-Performance Electrodes in Capacitive Deionization , 2015, Scientific Reports.
[19] Juan Li,et al. Liposome-based delivery systems for ginsenoside Rh2: in vitro and in vivo comparisons , 2015, Journal of Nanoparticle Research.
[20] Ruxangul Jamal,et al. Functionalization of Graphene Oxide and its Composite with Poly(3,4-ethylenedioxythiophene) as Electrode Material for Supercapacitors , 2015, Nanoscale Research Letters.
[21] S. Wu,et al. Current applications of graphene oxide in nanomedicine , 2015, International journal of nanomedicine.
[22] Mingwei Wang,et al. Graphene Oxide-Based Nanocarriers for Cancer Imaging and Drug Delivery. , 2015, Current pharmaceutical design.
[23] Changren Zhou,et al. Impact of graphene oxide on the structure and function of important multiple blood components by a dose-dependent pattern. , 2015, Journal of biomedical materials research. Part A.
[24] E. Sholkamy,et al. Anticancer activity of biostabilized selenium nanorods synthesized by Streptomyces bikiniensis strain Ess_amA-1 , 2015, International journal of nanomedicine.
[25] Chunjuan Chang,et al. Ginsenoside Rh2 Inhibits Cancer Stem-Like Cells in Skin Squamous Cell Carcinoma , 2015, Cellular Physiology and Biochemistry.
[26] D. Gomes,et al. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid , 2015, Expert review of anticancer therapy.
[27] F. Gramatica,et al. Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction. , 2015, Nanomedicine.
[28] He-da Zhang,et al. Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[29] T. Wei,et al. Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets. , 2014, Biomaterials.
[30] Xian‐Zheng Zhang,et al. Multifunctional Enveloped Mesoporous Silica Nanoparticles for Subcellular Co-delivery of Drug and Therapeutic Peptide , 2014, Scientific Reports.
[31] Marlus Chorilli,et al. Nanotechnology-based drug delivery systems for treatment of oral cancer: a review , 2014, International journal of nanomedicine.
[32] Gui-sheng Li,et al. Novel multicore niosomes based on double pH-sensitive mixed micelles for Ginsenoside Rh2 delivery , 2014, Artificial cells, nanomedicine, and biotechnology.
[33] N. Mei,et al. Assessment of the toxic potential of graphene family nanomaterials , 2014, Journal of food and drug analysis.
[34] A. Remaley,et al. Interferences from blood collection tube components on clinical chemistry assays , 2014, Biochemia medica.
[35] T. Seyfried,et al. Cancer as a metabolic disease: implications for novel therapeutics , 2013, Carcinogenesis.
[36] P. Hsieh,et al. The hemocompatibility of oxidized diamond nanocrystals for biomedical applications , 2013, Scientific Reports.
[37] K. Shroyer,et al. In Vitro Hematological and In Vivo Vasoactivity Assessment of Dextran Functionalized Graphene , 2013, Scientific Reports.
[38] Zhihai Liang,et al. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. , 2013, World journal of gastroenterology.
[39] Mehdi Shanbedi,et al. Studying of antifungal activity of functionalized multiwalled carbon nanotubes by microwave‐assisted technique , 2013 .
[40] Kun-Young Park,et al. Fermented Pu-erh tea increases in vitro anticancer activities in HT-29 cells and has antiangiogenetic effects on HUVECs. , 2013, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[41] Ronnie H. Fang,et al. Lipid- and Polymer-Based Nanostructures for Cancer Theranostics , 2012, Theranostics.
[42] Omid Akhavan,et al. Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. , 2012, Biomaterials.
[43] Jing-Rong Wang,et al. Inhibition of P-Glycoprotein Leads to Improved Oral Bioavailability of Compound K, an Anticancer Metabolite of Red Ginseng Extract Produced by Gut Microflora , 2012, Drug Metabolism and Disposition.
[44] S. Guterres,et al. Hemocompatibility of poly(ɛ-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. , 2012, International journal of pharmaceutics.
[45] Mehdi Shanbedi,et al. Efficient method for functionalization of carbon nanotubes by lysine and improved antimicrobial activity and water-dispersion , 2012 .
[46] Mehdi Shanbedi,et al. Enhanced antibacterial activity of amino acids-functionalized multi walled carbon nanotubes by a simple method. , 2012, Colloids and surfaces. B, Biointerfaces.
[47] J. Szebeni. Hemocompatibility testing for nanomedicines and biologicals: predictive assays for complement mediated infusion reactions , 2012 .
[48] P. Porporato,et al. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. , 2012, Current pharmaceutical design.
[49] Hui Wang,et al. Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action , 2012, Front. Pharmacol..
[50] R. Tiwari,et al. Drug delivery systems: An updated review , 2012, International journal of pharmaceutical investigation.
[51] Yong-Min Huh,et al. Gold nanostructures as photothermal therapy agent for cancer. , 2011, Anti-cancer agents in medicinal chemistry.
[52] Taijun Yin,et al. Enhancement of Oral Bioavailability of 20(S)-Ginsenoside Rh2 through Improved Understanding of Its Absorption and Efflux Mechanisms , 2011, Drug Metabolism and Disposition.
[53] Saeed Zeinali Heris,et al. One-pot, efficient functionalization of multi-walled carbon nanotubes with diamines by microwave method , 2011 .
[54] Christy L Haynes,et al. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. , 2011, ACS applied materials & interfaces.
[55] J. Hou,et al. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[56] T. He,et al. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. , 2011, Cancer letters.
[57] Robert Langer,et al. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. , 2010, Nano letters.
[58] Eunkyung Park,et al. Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt , 2010, British journal of pharmacology.
[59] Kenneth H. Norwich,et al. Le Chatelier's Principle in Sensation and Perception: Fractal-Like Enfolding at Different Scales , 2010, Front. Physio..
[60] Sailing He,et al. Multilayered polyelectrolyte-coated gold nanorods as multifunctional optical contrast agents for cancer cell imaging , 2010, Journal of Zhejiang University SCIENCE B.
[61] Shivendra V. Singh,et al. Ginsenoside Rh2-mediated G1 Phase Cell Cycle Arrest in Human Breast Cancer Cells Is Caused by p15Ink4B and p27Kip1-dependent Inhibition of Cyclin-dependent Kinases , 2009, Pharmaceutical Research.
[62] Wei Lu,et al. Gold-Based Magneto/Optical Nanostructures: Challenges for In Vivo Applications in Cancer Diagnostics and Therapy , 2009, Materials research bulletin.
[63] Hao Hong,et al. Applications of gold nanoparticles in cancer nanotechnology. , 2008, Nanotechnology, science and applications.
[64] W. D. de Jong,et al. Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.
[65] C. Rao,et al. Changes in the electronic structure and properties of graphene induced by molecular charge-transfer. , 2008, Chemical communications.
[66] H. R. Krishnamurthy,et al. Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor. , 2008, Nature nanotechnology.
[67] Z. Darżynkiewicz,et al. Analysis of apoptosis by cytometry using TUNEL assay. , 2008, Methods.
[68] Patrick Couvreur,et al. Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue. , 2008, Small.
[69] L. Bashawri,et al. THE APPROACH TO A PATIENT WITH A BLEEDING DISORDER: FOR THE PRIMARY CARE PHYSICIAN , 2007, Journal of family & community medicine.
[70] W. Jia,et al. Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy. , 2004, Canadian journal of physiology and pharmacology.
[71] S. Ko,et al. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells , 2004, Archives of pharmacal research.
[72] J. Lawry. Detection of apoptosis by the TUNEL assay. , 2004, Methods in molecular medicine.
[73] T. Ikejima,et al. Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. , 2002, Acta pharmacologica Sinica.
[74] Yoonho Kim,et al. I-V characteristics and impedance spectroscopy of a single grain boundary in Nb-doped SrTiO3 , 1999 .
[75] B. Fredricsson,et al. Changes in human sperm chromatin stability during preparation for in-vitro fertilization. , 1990, International journal of andrology.